Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
Clinical trial NCT05239650 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05239650
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2025-10-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.